Article
Alterations in the hepatic microenvironment following direct-acting antiviral therapy for chronic hepatitis C
2025-02-18
Abstract excerpt
<h4>Background: </h4> and aims. The first direct-acting antivirals (DAAs) to treat the viral hepatitis C (HCV) became available in 2011. Despite numerous clinical studies of patient outcomes after treatment, few have evaluated changes in the liver microenvironment. Despite achieving sustained virologic response (SVR), patients may still experience adverse outcomes like cirrhosis and hepatocellular carcinoma. By co...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bc4b375e-dec1-5ceb-8da8-96f0579b78b7
- DOI
- 10.1101/2025.02.17.25321289
